CPhI North America
16 May 2017 - 18 May 2017
12:00 AM - 11:59 PM
Join us for lunch and an engaging panel discussion about the benefits of taking a 360-degree view of your CDMO engagement model. Four experts will offer valuable perspectives on their areas of expertise and why partnering with a single CDMO may offer your molecule its best chance at success.
- The Economics View, from Joe DiMasi, Director of Economic Analysis, Tufts University
- The Early Development Science View, from Anil Kane, Executive Director and Head of Formulation Sciences, Patheon
- The Consultant View, CMC Consultant, Small and Emerging Pharma
- The Executive View, Senior Executive, Small and Emerging Pharma
You’ll hear about the economics of a more holistic drug development and manufacturing model, challenges and opportunities in development, business-centric lessons learned, tips on meeting critical milestones, and how to meet your investor’s financial expectations.
Pennsylvania Convention Center